Innovative Eyewear CEO sells 27,738 LUCY shares

Innovative Eyewear Inc (LUCY) reported that Chief Executive Officer and director Harrison R. Gross had both awards and sales of Common Stock.

Rhea-AI Filing Summary

Innovative Eyewear Inc (LUCY) reported that Chief Executive Officer and director Harrison R. Gross had both awards and sales of Common Stock. On April 2, 2026 and August 19, 2026, he received 24,600 shares on each date as a grant or award at $0.00 per share. On those same dates he sold shares in open market or private transactions, including 13,764 shares at an average price of $1.0658, 8,252 shares at an average price of $0.6916, and 5,722 shares at an average price of $0.705, with each price disclosed as a weighted average over multiple trades.

Insider Trade Summary

Net Seller: 27,738 shares

Net Sell 5 txns

Insider Gross Harrison R.

Role Chief Executive Officer

Sold 27,738 shs ($24K)

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	24,600	$0.00	$0.00
Sale	Common Stock F2	8,252	$0.6916	$6K
Sale	Common Stock F3	5,722	$0.705	$4K
Grant/Award	Common Stock	24,600	$0.00	$0.00
Sale	Common Stock F1	13,764	$1.0658	$15K

Holdings After Transaction: Common Stock — 35,195 shares (Direct)

Footnotes (3)

1. F1. The price reported in Column 4 is an average price of $1.0658. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
2. F2. The price reported in Column 4 is an average price of $0.6916. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
3. F3. The price reported in Column 4 is an average price of $0.705. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Key Figures

Grant shares on April 2, 2026: 24,600 shares of Common Stock Grant shares on August 19, 2026: 24,600 shares of Common Stock Total shares sold: 27,738 shares of Common Stock +3 more

6 metrics

Grant shares on April 2, 2026 24,600 shares of Common Stock Award to Harrison R. Gross at $0.00 per share

Grant shares on August 19, 2026 24,600 shares of Common Stock Award to Harrison R. Gross at $0.00 per share

Total shares sold 27,738 shares of Common Stock SellShares figure in transaction summary

Average sale price for 13,764-share block $1.0658 per share Open market or private sale on April 2, 2026 with footnote F1

Average sale price for 8,252-share block $0.6916 per share Open market or private sale on August 19, 2026 with footnote F2

Average sale price for 5,722-share block $0.705 per share Open market or private sale on August 19, 2026 with footnote F3

Key Terms

Grant, award, or other acquisition, Sale in open market or private transaction, average price

3 terms

Grant, award, or other acquisition financial

"Transaction code description is "Grant, award, or other acquisition""

Sale in open market or private transaction financial

"Transaction code description is "Sale in open market or private transaction""

average price financial

"The price reported in Column 4 is an average price of $1.0658"

FAQ

What insider transactions did LUCY CEO Harrison R. Gross report in this Form 4?

Harrison R. Gross reported two grants of 24,600 Common Stock shares each on April 2, 2026 and August 19, 2026, both at $0.00 per share, plus several open market or private sales of Common Stock on those same dates.

How many Innovative Eyewear (LUCY) shares did the CEO sell according to this filing?

The filing reports that Harrison R. Gross sold a total of 27,738 Common Stock shares in open market or private transactions, based on the transaction summary’s sellShares figure for the reported period.

What prices were received in the reported LUCY stock sales?

Reported sales of Innovative Eyewear Common Stock were at average prices of $1.0658 for 13,764 shares, $0.6916 for 8,252 shares, and $0.705 for 5,722 shares. Each price is disclosed as an average price over multiple trades in a range.

Were the reported LUCY grants to the CEO purchased or awarded?

The reported acquisitions of LUCY Common Stock were grants or awards, not market purchases. Each of the two transactions for 24,600 shares is coded “A” as a grant, award, or other acquisition at $0.00 per share.

Does this LUCY Form 4 indicate trades under a Rule 10b5-1 plan?

The document-level indicator for Rule 10b5-1 plans is false, and the footnotes do not state that any transaction was made under a trading plan. The filing therefore does not characterize these trades as conducted under Rule 10b5-1.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/24/2026 - 04:46 PM Accepted by SEC EDGAR 08/24/2026 - 04:45 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gross Harrison R.

(Last) (First) (Middle)

C/O INNOVATIVE EYEWEAR INC.

11900 BISCAYNE BLVD., SUITE 630

(Street)

MIAMI FLORIDA 33181

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Innovative Eyewear Inc [ LUCY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/02/2026		A		24,600	A	$0.00	38,333	D
Common Stock	04/02/2026		S		13,764	D	$1.0658(1)	24,569	D
Common Stock	08/19/2026		A		24,600	A	$0.00	49,169	D
Common Stock	08/19/2026		S		8,252	D	$0.6916(2)	40,917	D
Common Stock	08/19/2026		S		5,722	D	$0.705(3)	35,195	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is an average price of $1.0658. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

2. The price reported in Column 4 is an average price of $0.6916. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

3. The price reported in Column 4 is an average price of $0.705. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

	/s/ Harrison Gross	08/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)